Global Circular RNA Generation Technology Supply, Demand and Key Producers, 2026-2032
The global Circular RNA Generation Technology market size is expected to reach $ 543 million by 2032, rising at a market growth of 27.1% CAGR during the forecast period (2026-2032).
Circular RNA generation technology comprises the methods and process systems used to produce covalently closed circular RNA through sequence design, DNA template construction, in vitro transcription, ribozyme-mediated self-splicing, enzymatic ligation, intracellular splicing, or vector-mediated expression. A complete manufacturing workflow generally includes precursor RNA design, transcription, circularization, removal of residual linear RNA and double-stranded RNA impurities, chromatographic purification, concentration and buffer exchange, structural confirmation, purity testing, expression activity evaluation, and delivery formulation development. Upstream inputs mainly include nucleotide triphosphates, modified nucleosides, DNA and plasmid templates, RNA polymerases, T4 RNA ligases, ribozyme elements, nucleases, buffers, chromatography media, ultrafiltration consumables, single-use bioprocessing materials, analytical reagents, and lipid nanoparticle materials. Downstream customers include RNA drug developers, vaccine companies, gene and cell therapy companies, pharmaceutical companies, CRO/CDMO providers, research institutes, and hospital research centers. The industry's gross margin in 2025 is estimated at approximately 45%?65%.
The circular RNA generation technology market is currently transitioning from a research-tool market into an enabling infrastructure market for RNA drug development. Research-grade custom synthesis, vector construction, and circularization kits continue to represent the basic demand base, while faster growth is occurring in process development, impurity control, analytical method establishment, and GMP manufacturing. Suppliers can generally be divided into three groups: therapeutic developers with proprietary circularization platforms, life-science companies providing research-grade synthesis and kits, and RNA CRO/CDMO companies capable of producing clinical-grade drug substance and formulated products. The United States and China are currently the most active supply regions. Chinese companies have established a relatively broad presence in custom synthesis, process services, and integrated manufacturing, while U.S. companies are more active in proprietary platforms, technology licensing, and therapeutic translation.
Future technology development will shift from maximizing circularization yield alone toward the combined optimization of product integrity, scarless ligation, sequence flexibility, long-transcript compatibility, and manufacturing reproducibility. Conventional PIE approaches have a relatively mature research foundation, but may introduce residual foreign sequences and constrain some sequence designs. Enzymatic ligation approaches can provide more flexible or scarless products, but impose greater requirements on terminal structure, splint design, and enzyme cost. New intact-intron self-splicing, nickless circularization, and integrated circularization-purification technologies are emerging and may reduce impurity burdens and downstream purification complexity. In vitro and intracellular generation routes are expected to coexist, with the former offering better manufacturing control and the latter supporting sustained expression in gene therapy and in vivo cell-reprogramming applications.
Market growth is being driven by the development of next-generation RNA drugs, therapeutic vaccines, in vivo cell therapies, protein-replacement therapies, and genetic medicines. Once circular RNA programs advance into clinical development, demand expands beyond basic RNA synthesis to include high-purity drug substance, residual linear RNA and double-stranded RNA testing, structural characterization, translation-efficiency testing, aseptic production, and regulatory documentation. This substantially increases the value of each project. Downstream developers are also increasingly outsourcing sequence design, template preparation, circularization, purification, analytics, and LNP formulation to integrated suppliers in order to reduce technology-transfer risks and accelerate regulatory submissions. Entry by large pharmaceutical companies and expansion by specialist CDMOs are expected to support more standardized technical and supply-chain practices.
The main barriers are the lack of harmonized evaluation standards across circularization methods and the fact that a high circularization rate does not necessarily result in high purity, strong expression, or low immunogenicity. Uncircularized precursors, mis-ligated products, residual linear RNA, double-stranded RNA, truncated transcripts, and residual DNA can all affect safety and biological activity, placing substantial demands on purification and analytical methods. Long-sequence circularization, batch reproducibility, manufacturing scale-up, enzyme costs, and limited regulatory standards remain major industrialization challenges. The patent landscape is also complex, with overlapping claims covering PIE systems, ligase methods, translation elements, purification processes, and delivery technologies, creating uncertainty around freedom to operate and commercial licensing.
This report studies the global Circular RNA Generation Technology demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Circular RNA Generation Technology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Circular RNA Generation Technology that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Circular RNA Generation Technology total market, 2021-2032, (USD Million)
Global Circular RNA Generation Technology total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Circular RNA Generation Technology total market, key domestic companies, and share, (USD Million)
Global Circular RNA Generation Technology revenue by player, revenue and market share 2021-2026, (USD Million)
Global Circular RNA Generation Technology total market by Type, CAGR, 2021-2032, (USD Million)
Global Circular RNA Generation Technology total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Circular RNA Generation Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GenScript Biotech Corporation, Guangzhou Geneseed Biotech, uBriGene Biosciences, Yaohai Bio-Pharma, Creative Biogene, SBS Genetech, Orna Therapeutics, RiboX Therapeutics, Sail Biomedicines, Shanghai CirCode Biomed, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Circular RNA Generation Technology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Circular RNA Generation Technology Market, By Region:
1. How big is the global Circular RNA Generation Technology market?
2. What is the demand of the global Circular RNA Generation Technology market?
3. What is the year over year growth of the global Circular RNA Generation Technology market?
4. What is the total value of the global Circular RNA Generation Technology market?
5. Who are the Major Players in the global Circular RNA Generation Technology market?
6. What are the growth factors driving the market demand?
Circular RNA generation technology comprises the methods and process systems used to produce covalently closed circular RNA through sequence design, DNA template construction, in vitro transcription, ribozyme-mediated self-splicing, enzymatic ligation, intracellular splicing, or vector-mediated expression. A complete manufacturing workflow generally includes precursor RNA design, transcription, circularization, removal of residual linear RNA and double-stranded RNA impurities, chromatographic purification, concentration and buffer exchange, structural confirmation, purity testing, expression activity evaluation, and delivery formulation development. Upstream inputs mainly include nucleotide triphosphates, modified nucleosides, DNA and plasmid templates, RNA polymerases, T4 RNA ligases, ribozyme elements, nucleases, buffers, chromatography media, ultrafiltration consumables, single-use bioprocessing materials, analytical reagents, and lipid nanoparticle materials. Downstream customers include RNA drug developers, vaccine companies, gene and cell therapy companies, pharmaceutical companies, CRO/CDMO providers, research institutes, and hospital research centers. The industry's gross margin in 2025 is estimated at approximately 45%?65%.
The circular RNA generation technology market is currently transitioning from a research-tool market into an enabling infrastructure market for RNA drug development. Research-grade custom synthesis, vector construction, and circularization kits continue to represent the basic demand base, while faster growth is occurring in process development, impurity control, analytical method establishment, and GMP manufacturing. Suppliers can generally be divided into three groups: therapeutic developers with proprietary circularization platforms, life-science companies providing research-grade synthesis and kits, and RNA CRO/CDMO companies capable of producing clinical-grade drug substance and formulated products. The United States and China are currently the most active supply regions. Chinese companies have established a relatively broad presence in custom synthesis, process services, and integrated manufacturing, while U.S. companies are more active in proprietary platforms, technology licensing, and therapeutic translation.
Future technology development will shift from maximizing circularization yield alone toward the combined optimization of product integrity, scarless ligation, sequence flexibility, long-transcript compatibility, and manufacturing reproducibility. Conventional PIE approaches have a relatively mature research foundation, but may introduce residual foreign sequences and constrain some sequence designs. Enzymatic ligation approaches can provide more flexible or scarless products, but impose greater requirements on terminal structure, splint design, and enzyme cost. New intact-intron self-splicing, nickless circularization, and integrated circularization-purification technologies are emerging and may reduce impurity burdens and downstream purification complexity. In vitro and intracellular generation routes are expected to coexist, with the former offering better manufacturing control and the latter supporting sustained expression in gene therapy and in vivo cell-reprogramming applications.
Market growth is being driven by the development of next-generation RNA drugs, therapeutic vaccines, in vivo cell therapies, protein-replacement therapies, and genetic medicines. Once circular RNA programs advance into clinical development, demand expands beyond basic RNA synthesis to include high-purity drug substance, residual linear RNA and double-stranded RNA testing, structural characterization, translation-efficiency testing, aseptic production, and regulatory documentation. This substantially increases the value of each project. Downstream developers are also increasingly outsourcing sequence design, template preparation, circularization, purification, analytics, and LNP formulation to integrated suppliers in order to reduce technology-transfer risks and accelerate regulatory submissions. Entry by large pharmaceutical companies and expansion by specialist CDMOs are expected to support more standardized technical and supply-chain practices.
The main barriers are the lack of harmonized evaluation standards across circularization methods and the fact that a high circularization rate does not necessarily result in high purity, strong expression, or low immunogenicity. Uncircularized precursors, mis-ligated products, residual linear RNA, double-stranded RNA, truncated transcripts, and residual DNA can all affect safety and biological activity, placing substantial demands on purification and analytical methods. Long-sequence circularization, batch reproducibility, manufacturing scale-up, enzyme costs, and limited regulatory standards remain major industrialization challenges. The patent landscape is also complex, with overlapping claims covering PIE systems, ligase methods, translation elements, purification processes, and delivery technologies, creating uncertainty around freedom to operate and commercial licensing.
This report studies the global Circular RNA Generation Technology demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Circular RNA Generation Technology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Circular RNA Generation Technology that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Circular RNA Generation Technology total market, 2021-2032, (USD Million)
Global Circular RNA Generation Technology total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Circular RNA Generation Technology total market, key domestic companies, and share, (USD Million)
Global Circular RNA Generation Technology revenue by player, revenue and market share 2021-2026, (USD Million)
Global Circular RNA Generation Technology total market by Type, CAGR, 2021-2032, (USD Million)
Global Circular RNA Generation Technology total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Circular RNA Generation Technology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GenScript Biotech Corporation, Guangzhou Geneseed Biotech, uBriGene Biosciences, Yaohai Bio-Pharma, Creative Biogene, SBS Genetech, Orna Therapeutics, RiboX Therapeutics, Sail Biomedicines, Shanghai CirCode Biomed, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Circular RNA Generation Technology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Circular RNA Generation Technology Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- In Vitro Generation
- Intracellular Generation
- Ribozyme-Mediated Circularization
- Enzymatic Ligation
- Other
- Group I Intron-Based
- Group II Intron-Based
- Other
- Pharmaceutical and Biotechnology Companies
- CRO and CDMO Companies
- Other
- GenScript Biotech Corporation
- Guangzhou Geneseed Biotech
- uBriGene Biosciences
- Yaohai Bio-Pharma
- Creative Biogene
- SBS Genetech
- Orna Therapeutics
- RiboX Therapeutics
- Sail Biomedicines
- Shanghai CirCode Biomed
- Therorna
- Circio Holding
- Chimerna Therapeutics
- Rznomics
1. How big is the global Circular RNA Generation Technology market?
2. What is the demand of the global Circular RNA Generation Technology market?
3. What is the year over year growth of the global Circular RNA Generation Technology market?
4. What is the total value of the global Circular RNA Generation Technology market?
5. Who are the Major Players in the global Circular RNA Generation Technology market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Circular RNA Generation Technology Introduction
1.2 World Circular RNA Generation Technology Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Circular RNA Generation Technology Total Market by Region (by Headquarter Location)
1.3.1 World Circular RNA Generation Technology Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.3.3 China Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.3.4 Europe Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.3.5 Japan Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.3.6 South Korea Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.3.7 ASEAN Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.3.8 India Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Circular RNA Generation Technology Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Circular RNA Generation Technology Consumption Value (2021-2032)
2.2 World Circular RNA Generation Technology Consumption Value by Region
2.2.1 World Circular RNA Generation Technology Consumption Value by Region (2021-2026)
2.2.2 World Circular RNA Generation Technology Consumption Value Forecast by Region (2027-2032)
2.3 United States Circular RNA Generation Technology Consumption Value (2021-2032)
2.4 China Circular RNA Generation Technology Consumption Value (2021-2032)
2.5 Europe Circular RNA Generation Technology Consumption Value (2021-2032)
2.6 Japan Circular RNA Generation Technology Consumption Value (2021-2032)
2.7 South Korea Circular RNA Generation Technology Consumption Value (2021-2032)
2.8 ASEAN Circular RNA Generation Technology Consumption Value (2021-2032)
2.9 India Circular RNA Generation Technology Consumption Value (2021-2032)
3 WORLD CIRCULAR RNA GENERATION TECHNOLOGY COMPANIES COMPETITIVE ANALYSIS
3.1 World Circular RNA Generation Technology Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Circular RNA Generation Technology Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Circular RNA Generation Technology in 2025
3.2.3 Global Concentration Ratios (CR8) for Circular RNA Generation Technology in 2025
3.3 Circular RNA Generation Technology Company Evaluation Quadrant
3.4 Circular RNA Generation Technology Market: Overall Company Footprint Analysis
3.4.1 Circular RNA Generation Technology Market: Region Footprint
3.4.2 Circular RNA Generation Technology Market: Company Product Type Footprint
3.4.3 Circular RNA Generation Technology Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Circular RNA Generation Technology Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Circular RNA Generation Technology Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Circular RNA Generation Technology Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Circular RNA Generation Technology Consumption Value Comparison
4.2.1 United States VS China: Circular RNA Generation Technology Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Circular RNA Generation Technology Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Circular RNA Generation Technology Companies and Market Share, 2021-2026
4.3.1 United States Based Circular RNA Generation Technology Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Circular RNA Generation Technology Revenue, (2021-2026)
4.4 China Based Companies Circular RNA Generation Technology Revenue and Market Share, 2021-2026
4.4.1 China Based Circular RNA Generation Technology Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Circular RNA Generation Technology Revenue, (2021-2026)
4.5 Rest of World Based Circular RNA Generation Technology Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Circular RNA Generation Technology Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Circular RNA Generation Technology Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Circular RNA Generation Technology Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 In Vitro Generation
5.2.2 Intracellular Generation
5.3 Market Segment by Type
5.3.1 World Circular RNA Generation Technology Market Size by Type (2021-2026)
5.3.2 World Circular RNA Generation Technology Market Size by Type (2027-2032)
5.3.3 World Circular RNA Generation Technology Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CIRCULARIZATION METHOD
6.1 World Circular RNA Generation Technology Market Size Overview by Circularization Method: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Circularization Method
6.2.1 Ribozyme-Mediated Circularization
6.2.2 Enzymatic Ligation
6.2.3 Other
6.3 Market Segment by Circularization Method
6.3.1 World Circular RNA Generation Technology Market Size by Circularization Method (2021-2026)
6.3.2 World Circular RNA Generation Technology Market Size by Circularization Method (2027-2032)
6.3.3 World Circular RNA Generation Technology Market Size Market Share by Circularization Method (2027-2032)
7 MARKET ANALYSIS BY RIBOZYME ROUTE
7.1 World Circular RNA Generation Technology Market Size Overview by Ribozyme Route: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Ribozyme Route
7.2.1 Group I Intron-Based
7.2.2 Group II Intron-Based
7.2.3 Other
7.3 Market Segment by Ribozyme Route
7.3.1 World Circular RNA Generation Technology Market Size by Ribozyme Route (2021-2026)
7.3.2 World Circular RNA Generation Technology Market Size by Ribozyme Route (2027-2032)
7.3.3 World Circular RNA Generation Technology Market Size Market Share by Ribozyme Route (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Circular RNA Generation Technology Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical and Biotechnology Companies
8.2.2 CRO and CDMO Companies
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Circular RNA Generation Technology Market Size by Application (2021-2026)
8.3.2 World Circular RNA Generation Technology Market Size by Application (2027-2032)
8.3.3 World Circular RNA Generation Technology Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 GenScript Biotech Corporation
9.1.1 GenScript Biotech Corporation Details
9.1.2 GenScript Biotech Corporation Major Business
9.1.3 GenScript Biotech Corporation Circular RNA Generation Technology Product and Services
9.1.4 GenScript Biotech Corporation Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 GenScript Biotech Corporation Recent Developments/Updates
9.1.6 GenScript Biotech Corporation Competitive Strengths & Weaknesses
9.2 Guangzhou Geneseed Biotech
9.2.1 Guangzhou Geneseed Biotech Details
9.2.2 Guangzhou Geneseed Biotech Major Business
9.2.3 Guangzhou Geneseed Biotech Circular RNA Generation Technology Product and Services
9.2.4 Guangzhou Geneseed Biotech Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Guangzhou Geneseed Biotech Recent Developments/Updates
9.2.6 Guangzhou Geneseed Biotech Competitive Strengths & Weaknesses
9.3 uBriGene Biosciences
9.3.1 uBriGene Biosciences Details
9.3.2 uBriGene Biosciences Major Business
9.3.3 uBriGene Biosciences Circular RNA Generation Technology Product and Services
9.3.4 uBriGene Biosciences Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 uBriGene Biosciences Recent Developments/Updates
9.3.6 uBriGene Biosciences Competitive Strengths & Weaknesses
9.4 Yaohai Bio-Pharma
9.4.1 Yaohai Bio-Pharma Details
9.4.2 Yaohai Bio-Pharma Major Business
9.4.3 Yaohai Bio-Pharma Circular RNA Generation Technology Product and Services
9.4.4 Yaohai Bio-Pharma Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Yaohai Bio-Pharma Recent Developments/Updates
9.4.6 Yaohai Bio-Pharma Competitive Strengths & Weaknesses
9.5 Creative Biogene
9.5.1 Creative Biogene Details
9.5.2 Creative Biogene Major Business
9.5.3 Creative Biogene Circular RNA Generation Technology Product and Services
9.5.4 Creative Biogene Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Creative Biogene Recent Developments/Updates
9.5.6 Creative Biogene Competitive Strengths & Weaknesses
9.6 SBS Genetech
9.6.1 SBS Genetech Details
9.6.2 SBS Genetech Major Business
9.6.3 SBS Genetech Circular RNA Generation Technology Product and Services
9.6.4 SBS Genetech Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 SBS Genetech Recent Developments/Updates
9.6.6 SBS Genetech Competitive Strengths & Weaknesses
9.7 Orna Therapeutics
9.7.1 Orna Therapeutics Details
9.7.2 Orna Therapeutics Major Business
9.7.3 Orna Therapeutics Circular RNA Generation Technology Product and Services
9.7.4 Orna Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Orna Therapeutics Recent Developments/Updates
9.7.6 Orna Therapeutics Competitive Strengths & Weaknesses
9.8 RiboX Therapeutics
9.8.1 RiboX Therapeutics Details
9.8.2 RiboX Therapeutics Major Business
9.8.3 RiboX Therapeutics Circular RNA Generation Technology Product and Services
9.8.4 RiboX Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 RiboX Therapeutics Recent Developments/Updates
9.8.6 RiboX Therapeutics Competitive Strengths & Weaknesses
9.9 Sail Biomedicines
9.9.1 Sail Biomedicines Details
9.9.2 Sail Biomedicines Major Business
9.9.3 Sail Biomedicines Circular RNA Generation Technology Product and Services
9.9.4 Sail Biomedicines Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Sail Biomedicines Recent Developments/Updates
9.9.6 Sail Biomedicines Competitive Strengths & Weaknesses
9.10 Shanghai CirCode Biomed
9.10.1 Shanghai CirCode Biomed Details
9.10.2 Shanghai CirCode Biomed Major Business
9.10.3 Shanghai CirCode Biomed Circular RNA Generation Technology Product and Services
9.10.4 Shanghai CirCode Biomed Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Shanghai CirCode Biomed Recent Developments/Updates
9.10.6 Shanghai CirCode Biomed Competitive Strengths & Weaknesses
9.11 Therorna
9.11.1 Therorna Details
9.11.2 Therorna Major Business
9.11.3 Therorna Circular RNA Generation Technology Product and Services
9.11.4 Therorna Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Therorna Recent Developments/Updates
9.11.6 Therorna Competitive Strengths & Weaknesses
9.12 Circio Holding
9.12.1 Circio Holding Details
9.12.2 Circio Holding Major Business
9.12.3 Circio Holding Circular RNA Generation Technology Product and Services
9.12.4 Circio Holding Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Circio Holding Recent Developments/Updates
9.12.6 Circio Holding Competitive Strengths & Weaknesses
9.13 Chimerna Therapeutics
9.13.1 Chimerna Therapeutics Details
9.13.2 Chimerna Therapeutics Major Business
9.13.3 Chimerna Therapeutics Circular RNA Generation Technology Product and Services
9.13.4 Chimerna Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Chimerna Therapeutics Recent Developments/Updates
9.13.6 Chimerna Therapeutics Competitive Strengths & Weaknesses
9.14 Rznomics
9.14.1 Rznomics Details
9.14.2 Rznomics Major Business
9.14.3 Rznomics Circular RNA Generation Technology Product and Services
9.14.4 Rznomics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Rznomics Recent Developments/Updates
9.14.6 Rznomics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Circular RNA Generation Technology Industry Chain
10.2 Circular RNA Generation Technology Upstream Analysis
10.3 Circular RNA Generation Technology Midstream Analysis
10.4 Circular RNA Generation Technology Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Circular RNA Generation Technology Introduction
1.2 World Circular RNA Generation Technology Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Circular RNA Generation Technology Total Market by Region (by Headquarter Location)
1.3.1 World Circular RNA Generation Technology Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.3.3 China Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.3.4 Europe Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.3.5 Japan Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.3.6 South Korea Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.3.7 ASEAN Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.3.8 India Based Company Circular RNA Generation Technology Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Circular RNA Generation Technology Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Circular RNA Generation Technology Consumption Value (2021-2032)
2.2 World Circular RNA Generation Technology Consumption Value by Region
2.2.1 World Circular RNA Generation Technology Consumption Value by Region (2021-2026)
2.2.2 World Circular RNA Generation Technology Consumption Value Forecast by Region (2027-2032)
2.3 United States Circular RNA Generation Technology Consumption Value (2021-2032)
2.4 China Circular RNA Generation Technology Consumption Value (2021-2032)
2.5 Europe Circular RNA Generation Technology Consumption Value (2021-2032)
2.6 Japan Circular RNA Generation Technology Consumption Value (2021-2032)
2.7 South Korea Circular RNA Generation Technology Consumption Value (2021-2032)
2.8 ASEAN Circular RNA Generation Technology Consumption Value (2021-2032)
2.9 India Circular RNA Generation Technology Consumption Value (2021-2032)
3 WORLD CIRCULAR RNA GENERATION TECHNOLOGY COMPANIES COMPETITIVE ANALYSIS
3.1 World Circular RNA Generation Technology Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Circular RNA Generation Technology Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Circular RNA Generation Technology in 2025
3.2.3 Global Concentration Ratios (CR8) for Circular RNA Generation Technology in 2025
3.3 Circular RNA Generation Technology Company Evaluation Quadrant
3.4 Circular RNA Generation Technology Market: Overall Company Footprint Analysis
3.4.1 Circular RNA Generation Technology Market: Region Footprint
3.4.2 Circular RNA Generation Technology Market: Company Product Type Footprint
3.4.3 Circular RNA Generation Technology Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Circular RNA Generation Technology Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Circular RNA Generation Technology Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Circular RNA Generation Technology Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Circular RNA Generation Technology Consumption Value Comparison
4.2.1 United States VS China: Circular RNA Generation Technology Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Circular RNA Generation Technology Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Circular RNA Generation Technology Companies and Market Share, 2021-2026
4.3.1 United States Based Circular RNA Generation Technology Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Circular RNA Generation Technology Revenue, (2021-2026)
4.4 China Based Companies Circular RNA Generation Technology Revenue and Market Share, 2021-2026
4.4.1 China Based Circular RNA Generation Technology Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Circular RNA Generation Technology Revenue, (2021-2026)
4.5 Rest of World Based Circular RNA Generation Technology Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Circular RNA Generation Technology Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Circular RNA Generation Technology Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Circular RNA Generation Technology Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 In Vitro Generation
5.2.2 Intracellular Generation
5.3 Market Segment by Type
5.3.1 World Circular RNA Generation Technology Market Size by Type (2021-2026)
5.3.2 World Circular RNA Generation Technology Market Size by Type (2027-2032)
5.3.3 World Circular RNA Generation Technology Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY CIRCULARIZATION METHOD
6.1 World Circular RNA Generation Technology Market Size Overview by Circularization Method: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Circularization Method
6.2.1 Ribozyme-Mediated Circularization
6.2.2 Enzymatic Ligation
6.2.3 Other
6.3 Market Segment by Circularization Method
6.3.1 World Circular RNA Generation Technology Market Size by Circularization Method (2021-2026)
6.3.2 World Circular RNA Generation Technology Market Size by Circularization Method (2027-2032)
6.3.3 World Circular RNA Generation Technology Market Size Market Share by Circularization Method (2027-2032)
7 MARKET ANALYSIS BY RIBOZYME ROUTE
7.1 World Circular RNA Generation Technology Market Size Overview by Ribozyme Route: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Ribozyme Route
7.2.1 Group I Intron-Based
7.2.2 Group II Intron-Based
7.2.3 Other
7.3 Market Segment by Ribozyme Route
7.3.1 World Circular RNA Generation Technology Market Size by Ribozyme Route (2021-2026)
7.3.2 World Circular RNA Generation Technology Market Size by Ribozyme Route (2027-2032)
7.3.3 World Circular RNA Generation Technology Market Size Market Share by Ribozyme Route (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Circular RNA Generation Technology Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Pharmaceutical and Biotechnology Companies
8.2.2 CRO and CDMO Companies
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Circular RNA Generation Technology Market Size by Application (2021-2026)
8.3.2 World Circular RNA Generation Technology Market Size by Application (2027-2032)
8.3.3 World Circular RNA Generation Technology Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 GenScript Biotech Corporation
9.1.1 GenScript Biotech Corporation Details
9.1.2 GenScript Biotech Corporation Major Business
9.1.3 GenScript Biotech Corporation Circular RNA Generation Technology Product and Services
9.1.4 GenScript Biotech Corporation Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 GenScript Biotech Corporation Recent Developments/Updates
9.1.6 GenScript Biotech Corporation Competitive Strengths & Weaknesses
9.2 Guangzhou Geneseed Biotech
9.2.1 Guangzhou Geneseed Biotech Details
9.2.2 Guangzhou Geneseed Biotech Major Business
9.2.3 Guangzhou Geneseed Biotech Circular RNA Generation Technology Product and Services
9.2.4 Guangzhou Geneseed Biotech Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Guangzhou Geneseed Biotech Recent Developments/Updates
9.2.6 Guangzhou Geneseed Biotech Competitive Strengths & Weaknesses
9.3 uBriGene Biosciences
9.3.1 uBriGene Biosciences Details
9.3.2 uBriGene Biosciences Major Business
9.3.3 uBriGene Biosciences Circular RNA Generation Technology Product and Services
9.3.4 uBriGene Biosciences Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 uBriGene Biosciences Recent Developments/Updates
9.3.6 uBriGene Biosciences Competitive Strengths & Weaknesses
9.4 Yaohai Bio-Pharma
9.4.1 Yaohai Bio-Pharma Details
9.4.2 Yaohai Bio-Pharma Major Business
9.4.3 Yaohai Bio-Pharma Circular RNA Generation Technology Product and Services
9.4.4 Yaohai Bio-Pharma Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Yaohai Bio-Pharma Recent Developments/Updates
9.4.6 Yaohai Bio-Pharma Competitive Strengths & Weaknesses
9.5 Creative Biogene
9.5.1 Creative Biogene Details
9.5.2 Creative Biogene Major Business
9.5.3 Creative Biogene Circular RNA Generation Technology Product and Services
9.5.4 Creative Biogene Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Creative Biogene Recent Developments/Updates
9.5.6 Creative Biogene Competitive Strengths & Weaknesses
9.6 SBS Genetech
9.6.1 SBS Genetech Details
9.6.2 SBS Genetech Major Business
9.6.3 SBS Genetech Circular RNA Generation Technology Product and Services
9.6.4 SBS Genetech Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 SBS Genetech Recent Developments/Updates
9.6.6 SBS Genetech Competitive Strengths & Weaknesses
9.7 Orna Therapeutics
9.7.1 Orna Therapeutics Details
9.7.2 Orna Therapeutics Major Business
9.7.3 Orna Therapeutics Circular RNA Generation Technology Product and Services
9.7.4 Orna Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Orna Therapeutics Recent Developments/Updates
9.7.6 Orna Therapeutics Competitive Strengths & Weaknesses
9.8 RiboX Therapeutics
9.8.1 RiboX Therapeutics Details
9.8.2 RiboX Therapeutics Major Business
9.8.3 RiboX Therapeutics Circular RNA Generation Technology Product and Services
9.8.4 RiboX Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 RiboX Therapeutics Recent Developments/Updates
9.8.6 RiboX Therapeutics Competitive Strengths & Weaknesses
9.9 Sail Biomedicines
9.9.1 Sail Biomedicines Details
9.9.2 Sail Biomedicines Major Business
9.9.3 Sail Biomedicines Circular RNA Generation Technology Product and Services
9.9.4 Sail Biomedicines Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Sail Biomedicines Recent Developments/Updates
9.9.6 Sail Biomedicines Competitive Strengths & Weaknesses
9.10 Shanghai CirCode Biomed
9.10.1 Shanghai CirCode Biomed Details
9.10.2 Shanghai CirCode Biomed Major Business
9.10.3 Shanghai CirCode Biomed Circular RNA Generation Technology Product and Services
9.10.4 Shanghai CirCode Biomed Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Shanghai CirCode Biomed Recent Developments/Updates
9.10.6 Shanghai CirCode Biomed Competitive Strengths & Weaknesses
9.11 Therorna
9.11.1 Therorna Details
9.11.2 Therorna Major Business
9.11.3 Therorna Circular RNA Generation Technology Product and Services
9.11.4 Therorna Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Therorna Recent Developments/Updates
9.11.6 Therorna Competitive Strengths & Weaknesses
9.12 Circio Holding
9.12.1 Circio Holding Details
9.12.2 Circio Holding Major Business
9.12.3 Circio Holding Circular RNA Generation Technology Product and Services
9.12.4 Circio Holding Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Circio Holding Recent Developments/Updates
9.12.6 Circio Holding Competitive Strengths & Weaknesses
9.13 Chimerna Therapeutics
9.13.1 Chimerna Therapeutics Details
9.13.2 Chimerna Therapeutics Major Business
9.13.3 Chimerna Therapeutics Circular RNA Generation Technology Product and Services
9.13.4 Chimerna Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Chimerna Therapeutics Recent Developments/Updates
9.13.6 Chimerna Therapeutics Competitive Strengths & Weaknesses
9.14 Rznomics
9.14.1 Rznomics Details
9.14.2 Rznomics Major Business
9.14.3 Rznomics Circular RNA Generation Technology Product and Services
9.14.4 Rznomics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Rznomics Recent Developments/Updates
9.14.6 Rznomics Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Circular RNA Generation Technology Industry Chain
10.2 Circular RNA Generation Technology Upstream Analysis
10.3 Circular RNA Generation Technology Midstream Analysis
10.4 Circular RNA Generation Technology Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Circular RNA Generation Technology Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Circular RNA Generation Technology Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Circular RNA Generation Technology Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Circular RNA Generation Technology Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Circular RNA Generation Technology Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Circular RNA Generation Technology Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Circular RNA Generation Technology Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Circular RNA Generation Technology Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Circular RNA Generation Technology Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Circular RNA Generation Technology Players in 2025
Table 12. World Circular RNA Generation Technology Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Circular RNA Generation Technology Company Evaluation Quadrant
Table 14. Head Office of Key Circular RNA Generation Technology Players
Table 15. Circular RNA Generation Technology Market: Company Product Type Footprint
Table 16. Circular RNA Generation Technology Market: Company Product Application Footprint
Table 17. Circular RNA Generation Technology Mergers & Acquisitions Activity
Table 18. United States VS China Circular RNA Generation Technology Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Circular RNA Generation Technology Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Circular RNA Generation Technology Companies, Headquarters (States, Country)
Table 21. United States Based Companies Circular RNA Generation Technology Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Circular RNA Generation Technology Revenue Market Share (2021-2026)
Table 23. China Based Circular RNA Generation Technology Companies, Headquarters (Province, Country)
Table 24. China Based Companies Circular RNA Generation Technology Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Circular RNA Generation Technology Revenue Market Share (2021-2026)
Table 26. Rest of World Based Circular RNA Generation Technology Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Circular RNA Generation Technology Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Circular RNA Generation Technology Revenue Market Share (2021-2026)
Table 29. World Circular RNA Generation Technology Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Circular RNA Generation Technology Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Circular RNA Generation Technology Market Size by Type (2027-2032) & (USD Million)
Table 32. World Circular RNA Generation Technology Market Size by Circularization Method, (USD Million), 2021 & 2025 & 2032
Table 33. World Circular RNA Generation Technology Market Size Value by Circularization Method (2021-2026) & (USD Million)
Table 34. World Circular RNA Generation Technology Market Size by Circularization Method (2027-2032) & (USD Million)
Table 35. World Circular RNA Generation Technology Market Size by Ribozyme Route, (USD Million), 2021 & 2025 & 2032
Table 36. World Circular RNA Generation Technology Market Size Value by Ribozyme Route (2021-2026) & (USD Million)
Table 37. World Circular RNA Generation Technology Market Size by Ribozyme Route (2027-2032) & (USD Million)
Table 38. World Circular RNA Generation Technology Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Circular RNA Generation Technology Market Size by Application (2021-2026) & (USD Million)
Table 40. World Circular RNA Generation Technology Market Size by Application (2027-2032) & (USD Million)
Table 41. GenScript Biotech Corporation Basic Information, Manufacturing Base and Competitors
Table 42. GenScript Biotech Corporation Major Business
Table 43. GenScript Biotech Corporation Circular RNA Generation Technology Product and Services
Table 44. GenScript Biotech Corporation Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GenScript Biotech Corporation Recent Developments/Updates
Table 46. GenScript Biotech Corporation Competitive Strengths & Weaknesses
Table 47. Guangzhou Geneseed Biotech Basic Information, Manufacturing Base and Competitors
Table 48. Guangzhou Geneseed Biotech Major Business
Table 49. Guangzhou Geneseed Biotech Circular RNA Generation Technology Product and Services
Table 50. Guangzhou Geneseed Biotech Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Guangzhou Geneseed Biotech Recent Developments/Updates
Table 52. Guangzhou Geneseed Biotech Competitive Strengths & Weaknesses
Table 53. uBriGene Biosciences Basic Information, Manufacturing Base and Competitors
Table 54. uBriGene Biosciences Major Business
Table 55. uBriGene Biosciences Circular RNA Generation Technology Product and Services
Table 56. uBriGene Biosciences Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. uBriGene Biosciences Recent Developments/Updates
Table 58. uBriGene Biosciences Competitive Strengths & Weaknesses
Table 59. Yaohai Bio-Pharma Basic Information, Manufacturing Base and Competitors
Table 60. Yaohai Bio-Pharma Major Business
Table 61. Yaohai Bio-Pharma Circular RNA Generation Technology Product and Services
Table 62. Yaohai Bio-Pharma Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Yaohai Bio-Pharma Recent Developments/Updates
Table 64. Yaohai Bio-Pharma Competitive Strengths & Weaknesses
Table 65. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 66. Creative Biogene Major Business
Table 67. Creative Biogene Circular RNA Generation Technology Product and Services
Table 68. Creative Biogene Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Creative Biogene Recent Developments/Updates
Table 70. Creative Biogene Competitive Strengths & Weaknesses
Table 71. SBS Genetech Basic Information, Manufacturing Base and Competitors
Table 72. SBS Genetech Major Business
Table 73. SBS Genetech Circular RNA Generation Technology Product and Services
Table 74. SBS Genetech Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. SBS Genetech Recent Developments/Updates
Table 76. SBS Genetech Competitive Strengths & Weaknesses
Table 77. Orna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 78. Orna Therapeutics Major Business
Table 79. Orna Therapeutics Circular RNA Generation Technology Product and Services
Table 80. Orna Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Orna Therapeutics Recent Developments/Updates
Table 82. Orna Therapeutics Competitive Strengths & Weaknesses
Table 83. RiboX Therapeutics Basic Information, Manufacturing Base and Competitors
Table 84. RiboX Therapeutics Major Business
Table 85. RiboX Therapeutics Circular RNA Generation Technology Product and Services
Table 86. RiboX Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. RiboX Therapeutics Recent Developments/Updates
Table 88. RiboX Therapeutics Competitive Strengths & Weaknesses
Table 89. Sail Biomedicines Basic Information, Manufacturing Base and Competitors
Table 90. Sail Biomedicines Major Business
Table 91. Sail Biomedicines Circular RNA Generation Technology Product and Services
Table 92. Sail Biomedicines Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Sail Biomedicines Recent Developments/Updates
Table 94. Sail Biomedicines Competitive Strengths & Weaknesses
Table 95. Shanghai CirCode Biomed Basic Information, Manufacturing Base and Competitors
Table 96. Shanghai CirCode Biomed Major Business
Table 97. Shanghai CirCode Biomed Circular RNA Generation Technology Product and Services
Table 98. Shanghai CirCode Biomed Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Shanghai CirCode Biomed Recent Developments/Updates
Table 100. Shanghai CirCode Biomed Competitive Strengths & Weaknesses
Table 101. Therorna Basic Information, Manufacturing Base and Competitors
Table 102. Therorna Major Business
Table 103. Therorna Circular RNA Generation Technology Product and Services
Table 104. Therorna Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Therorna Recent Developments/Updates
Table 106. Therorna Competitive Strengths & Weaknesses
Table 107. Circio Holding Basic Information, Manufacturing Base and Competitors
Table 108. Circio Holding Major Business
Table 109. Circio Holding Circular RNA Generation Technology Product and Services
Table 110. Circio Holding Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Circio Holding Recent Developments/Updates
Table 112. Circio Holding Competitive Strengths & Weaknesses
Table 113. Chimerna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 114. Chimerna Therapeutics Major Business
Table 115. Chimerna Therapeutics Circular RNA Generation Technology Product and Services
Table 116. Chimerna Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Chimerna Therapeutics Recent Developments/Updates
Table 118. Chimerna Therapeutics Competitive Strengths & Weaknesses
Table 119. Rznomics Basic Information, Manufacturing Base and Competitors
Table 120. Rznomics Major Business
Table 121. Rznomics Circular RNA Generation Technology Product and Services
Table 122. Rznomics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Rznomics Recent Developments/Updates
Table 124. Rznomics Competitive Strengths & Weaknesses
Table 125. Global Key Players of Circular RNA Generation Technology Upstream (Raw Materials)
Table 126. Global Circular RNA Generation Technology Typical Customers
Table 1. World Circular RNA Generation Technology Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Circular RNA Generation Technology Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Circular RNA Generation Technology Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Circular RNA Generation Technology Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Circular RNA Generation Technology Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Circular RNA Generation Technology Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Circular RNA Generation Technology Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Circular RNA Generation Technology Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Circular RNA Generation Technology Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Circular RNA Generation Technology Players in 2025
Table 12. World Circular RNA Generation Technology Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Circular RNA Generation Technology Company Evaluation Quadrant
Table 14. Head Office of Key Circular RNA Generation Technology Players
Table 15. Circular RNA Generation Technology Market: Company Product Type Footprint
Table 16. Circular RNA Generation Technology Market: Company Product Application Footprint
Table 17. Circular RNA Generation Technology Mergers & Acquisitions Activity
Table 18. United States VS China Circular RNA Generation Technology Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Circular RNA Generation Technology Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Circular RNA Generation Technology Companies, Headquarters (States, Country)
Table 21. United States Based Companies Circular RNA Generation Technology Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Circular RNA Generation Technology Revenue Market Share (2021-2026)
Table 23. China Based Circular RNA Generation Technology Companies, Headquarters (Province, Country)
Table 24. China Based Companies Circular RNA Generation Technology Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Circular RNA Generation Technology Revenue Market Share (2021-2026)
Table 26. Rest of World Based Circular RNA Generation Technology Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Circular RNA Generation Technology Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Circular RNA Generation Technology Revenue Market Share (2021-2026)
Table 29. World Circular RNA Generation Technology Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Circular RNA Generation Technology Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Circular RNA Generation Technology Market Size by Type (2027-2032) & (USD Million)
Table 32. World Circular RNA Generation Technology Market Size by Circularization Method, (USD Million), 2021 & 2025 & 2032
Table 33. World Circular RNA Generation Technology Market Size Value by Circularization Method (2021-2026) & (USD Million)
Table 34. World Circular RNA Generation Technology Market Size by Circularization Method (2027-2032) & (USD Million)
Table 35. World Circular RNA Generation Technology Market Size by Ribozyme Route, (USD Million), 2021 & 2025 & 2032
Table 36. World Circular RNA Generation Technology Market Size Value by Ribozyme Route (2021-2026) & (USD Million)
Table 37. World Circular RNA Generation Technology Market Size by Ribozyme Route (2027-2032) & (USD Million)
Table 38. World Circular RNA Generation Technology Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Circular RNA Generation Technology Market Size by Application (2021-2026) & (USD Million)
Table 40. World Circular RNA Generation Technology Market Size by Application (2027-2032) & (USD Million)
Table 41. GenScript Biotech Corporation Basic Information, Manufacturing Base and Competitors
Table 42. GenScript Biotech Corporation Major Business
Table 43. GenScript Biotech Corporation Circular RNA Generation Technology Product and Services
Table 44. GenScript Biotech Corporation Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. GenScript Biotech Corporation Recent Developments/Updates
Table 46. GenScript Biotech Corporation Competitive Strengths & Weaknesses
Table 47. Guangzhou Geneseed Biotech Basic Information, Manufacturing Base and Competitors
Table 48. Guangzhou Geneseed Biotech Major Business
Table 49. Guangzhou Geneseed Biotech Circular RNA Generation Technology Product and Services
Table 50. Guangzhou Geneseed Biotech Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Guangzhou Geneseed Biotech Recent Developments/Updates
Table 52. Guangzhou Geneseed Biotech Competitive Strengths & Weaknesses
Table 53. uBriGene Biosciences Basic Information, Manufacturing Base and Competitors
Table 54. uBriGene Biosciences Major Business
Table 55. uBriGene Biosciences Circular RNA Generation Technology Product and Services
Table 56. uBriGene Biosciences Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. uBriGene Biosciences Recent Developments/Updates
Table 58. uBriGene Biosciences Competitive Strengths & Weaknesses
Table 59. Yaohai Bio-Pharma Basic Information, Manufacturing Base and Competitors
Table 60. Yaohai Bio-Pharma Major Business
Table 61. Yaohai Bio-Pharma Circular RNA Generation Technology Product and Services
Table 62. Yaohai Bio-Pharma Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Yaohai Bio-Pharma Recent Developments/Updates
Table 64. Yaohai Bio-Pharma Competitive Strengths & Weaknesses
Table 65. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 66. Creative Biogene Major Business
Table 67. Creative Biogene Circular RNA Generation Technology Product and Services
Table 68. Creative Biogene Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Creative Biogene Recent Developments/Updates
Table 70. Creative Biogene Competitive Strengths & Weaknesses
Table 71. SBS Genetech Basic Information, Manufacturing Base and Competitors
Table 72. SBS Genetech Major Business
Table 73. SBS Genetech Circular RNA Generation Technology Product and Services
Table 74. SBS Genetech Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. SBS Genetech Recent Developments/Updates
Table 76. SBS Genetech Competitive Strengths & Weaknesses
Table 77. Orna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 78. Orna Therapeutics Major Business
Table 79. Orna Therapeutics Circular RNA Generation Technology Product and Services
Table 80. Orna Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Orna Therapeutics Recent Developments/Updates
Table 82. Orna Therapeutics Competitive Strengths & Weaknesses
Table 83. RiboX Therapeutics Basic Information, Manufacturing Base and Competitors
Table 84. RiboX Therapeutics Major Business
Table 85. RiboX Therapeutics Circular RNA Generation Technology Product and Services
Table 86. RiboX Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. RiboX Therapeutics Recent Developments/Updates
Table 88. RiboX Therapeutics Competitive Strengths & Weaknesses
Table 89. Sail Biomedicines Basic Information, Manufacturing Base and Competitors
Table 90. Sail Biomedicines Major Business
Table 91. Sail Biomedicines Circular RNA Generation Technology Product and Services
Table 92. Sail Biomedicines Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Sail Biomedicines Recent Developments/Updates
Table 94. Sail Biomedicines Competitive Strengths & Weaknesses
Table 95. Shanghai CirCode Biomed Basic Information, Manufacturing Base and Competitors
Table 96. Shanghai CirCode Biomed Major Business
Table 97. Shanghai CirCode Biomed Circular RNA Generation Technology Product and Services
Table 98. Shanghai CirCode Biomed Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Shanghai CirCode Biomed Recent Developments/Updates
Table 100. Shanghai CirCode Biomed Competitive Strengths & Weaknesses
Table 101. Therorna Basic Information, Manufacturing Base and Competitors
Table 102. Therorna Major Business
Table 103. Therorna Circular RNA Generation Technology Product and Services
Table 104. Therorna Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Therorna Recent Developments/Updates
Table 106. Therorna Competitive Strengths & Weaknesses
Table 107. Circio Holding Basic Information, Manufacturing Base and Competitors
Table 108. Circio Holding Major Business
Table 109. Circio Holding Circular RNA Generation Technology Product and Services
Table 110. Circio Holding Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Circio Holding Recent Developments/Updates
Table 112. Circio Holding Competitive Strengths & Weaknesses
Table 113. Chimerna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 114. Chimerna Therapeutics Major Business
Table 115. Chimerna Therapeutics Circular RNA Generation Technology Product and Services
Table 116. Chimerna Therapeutics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Chimerna Therapeutics Recent Developments/Updates
Table 118. Chimerna Therapeutics Competitive Strengths & Weaknesses
Table 119. Rznomics Basic Information, Manufacturing Base and Competitors
Table 120. Rznomics Major Business
Table 121. Rznomics Circular RNA Generation Technology Product and Services
Table 122. Rznomics Circular RNA Generation Technology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Rznomics Recent Developments/Updates
Table 124. Rznomics Competitive Strengths & Weaknesses
Table 125. Global Key Players of Circular RNA Generation Technology Upstream (Raw Materials)
Table 126. Global Circular RNA Generation Technology Typical Customers
LIST OF FIGURES
Figure 1. Circular RNA Generation Technology Picture
Figure 2. World Circular RNA Generation Technology Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Circular RNA Generation Technology Total Revenue (2021-2032) & (USD Million)
Figure 4. World Circular RNA Generation Technology Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Circular RNA Generation Technology Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 13. Circular RNA Generation Technology Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 16. World Circular RNA Generation Technology Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 18. China Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 23. India Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Circular RNA Generation Technology by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Circular RNA Generation Technology Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Circular RNA Generation Technology Markets in 2025
Figure 27. United States VS China: Circular RNA Generation Technology Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Circular RNA Generation Technology Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Circular RNA Generation Technology Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Circular RNA Generation Technology Market Size Market Share by Type in 2025
Figure 31. In Vitro Generation
Figure 32. Intracellular Generation
Figure 33. World Circular RNA Generation Technology Market Size Market Share by Type (2021-2032)
Figure 34. World Circular RNA Generation Technology Market Size by Circularization Method, (USD Million), 2021 & 2025 & 2032
Figure 35. World Circular RNA Generation Technology Market Size Market Share by Circularization Method in 2025
Figure 36. Ribozyme-Mediated Circularization
Figure 37. Enzymatic Ligation
Figure 38. Other
Figure 39. World Circular RNA Generation Technology Market Size Market Share by Circularization Method (2021-2032)
Figure 40. World Circular RNA Generation Technology Market Size by Ribozyme Route, (USD Million), 2021 & 2025 & 2032
Figure 41. World Circular RNA Generation Technology Market Size Market Share by Ribozyme Route in 2025
Figure 42. Group I Intron-Based
Figure 43. Group II Intron-Based
Figure 44. Other
Figure 45. World Circular RNA Generation Technology Market Size Market Share by Ribozyme Route (2021-2032)
Figure 46. World Circular RNA Generation Technology Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Circular RNA Generation Technology Market Size Market Share by Application in 2025
Figure 48. Pharmaceutical and Biotechnology Companies
Figure 49. CRO and CDMO Companies
Figure 50. Other
Figure 51. World Circular RNA Generation Technology Market Size Market Share by Application (2021-2032)
Figure 52. Circular RNA Generation Technology Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Circular RNA Generation Technology Picture
Figure 2. World Circular RNA Generation Technology Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Circular RNA Generation Technology Total Revenue (2021-2032) & (USD Million)
Figure 4. World Circular RNA Generation Technology Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Circular RNA Generation Technology Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Circular RNA Generation Technology Revenue (2021-2032) & (USD Million)
Figure 13. Circular RNA Generation Technology Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 16. World Circular RNA Generation Technology Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 18. China Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 23. India Circular RNA Generation Technology Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Circular RNA Generation Technology by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Circular RNA Generation Technology Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Circular RNA Generation Technology Markets in 2025
Figure 27. United States VS China: Circular RNA Generation Technology Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Circular RNA Generation Technology Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Circular RNA Generation Technology Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Circular RNA Generation Technology Market Size Market Share by Type in 2025
Figure 31. In Vitro Generation
Figure 32. Intracellular Generation
Figure 33. World Circular RNA Generation Technology Market Size Market Share by Type (2021-2032)
Figure 34. World Circular RNA Generation Technology Market Size by Circularization Method, (USD Million), 2021 & 2025 & 2032
Figure 35. World Circular RNA Generation Technology Market Size Market Share by Circularization Method in 2025
Figure 36. Ribozyme-Mediated Circularization
Figure 37. Enzymatic Ligation
Figure 38. Other
Figure 39. World Circular RNA Generation Technology Market Size Market Share by Circularization Method (2021-2032)
Figure 40. World Circular RNA Generation Technology Market Size by Ribozyme Route, (USD Million), 2021 & 2025 & 2032
Figure 41. World Circular RNA Generation Technology Market Size Market Share by Ribozyme Route in 2025
Figure 42. Group I Intron-Based
Figure 43. Group II Intron-Based
Figure 44. Other
Figure 45. World Circular RNA Generation Technology Market Size Market Share by Ribozyme Route (2021-2032)
Figure 46. World Circular RNA Generation Technology Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Circular RNA Generation Technology Market Size Market Share by Application in 2025
Figure 48. Pharmaceutical and Biotechnology Companies
Figure 49. CRO and CDMO Companies
Figure 50. Other
Figure 51. World Circular RNA Generation Technology Market Size Market Share by Application (2021-2032)
Figure 52. Circular RNA Generation Technology Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
